{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:09:05Z","timestamp":1786975745182,"version":"build-2736575974"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1001\/jamaoncol.2018.7220","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T11:01:05Z","timestamp":1552561265000},"page":"847","source":"Crossref","is-referenced-by-count":63,"title":["Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non\u2013Small Cell Lung Cancer"],"prefix":"10.1001","volume":"5","author":[{"given":"Alexander","family":"Sun","sequence":"first","affiliation":[{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[{"name":"NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania"},{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Wong","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gore","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Videtic","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Dutta","sequence":"additional","affiliation":[{"name":"Michigan Cancer Research Consortium CCOP, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Suntharalingam","sequence":"additional","affiliation":[{"name":"University of Maryland Medical System, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhchyau","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie E.","family":"Gaspar","sequence":"additional","affiliation":[{"name":"University of Colorado, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak","family":"Choy","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"coi180128r1","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain.","volume":"109","author":"Chen","year":"2007","journal-title":"Cancer"},{"issue":"31","key":"coi180128r2","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1200\/JCO.2007.12.5468","article-title":"Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.","volume":"25","author":"P\u00f6ttgen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi180128r3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1200\/JCO.2005.04.123","article-title":"High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.","volume":"23","author":"Mamon","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"coi180128r4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/00000421-200212000-00011","article-title":"Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer.","volume":"25","author":"Keith","year":"2002","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"coi180128r5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.","volume":"95","author":"Ceresoli","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"coi180128r6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/1097-0142(20010701)92:1&lt;&gt;1.0.CO;2-Z","article-title":"Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma.","volume":"92","author":"Law","year":"2001","journal-title":"Cancer"},{"issue":"9","key":"coi180128r7","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1200\/JCO.1999.17.9.2700","article-title":"Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.","volume":"17","author":"Stuschke","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"coi180128r8","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1200\/JCO.1997.15.2.712","article-title":"Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.","volume":"15","author":"Choi","year":"1997","journal-title":"J Clin Oncol"},{"issue":"8","key":"coi180128r9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","article-title":"Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.","volume":"13","author":"Albain","year":"1995","journal-title":"J Clin Oncol"},{"issue":"8","key":"coi180128r10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1200\/JCO.1992.10.8.1237","article-title":"Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.","volume":"10","author":"Strauss","year":"1992","journal-title":"J Clin Oncol"},{"issue":"4","key":"coi180128r11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jnci\/83.4.266","article-title":"Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group.","volume":"83","author":"Weiden","year":"1991","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi180128r12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/(ISSN)1096-9098","article-title":"Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients.","volume":"40","author":"Skarin","year":"1989","journal-title":"J Surg Oncol"},{"issue":"13","key":"coi180128r13","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1200\/JCO.2005.08.026","article-title":"Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.","volume":"23","author":"Gaspar","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi180128r14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lungcan.2004.12.004","article-title":"Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?","volume":"49","author":"Carolan","year":"2005","journal-title":"Lung Cancer"},{"issue":"16","key":"coi180128r15","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1200\/JCO.2002.03.055","article-title":"Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.","volume":"20","author":"Albain","year":"2002","journal-title":"J Clin Oncol"},{"key":"coi180128r16","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Patterns of relapse of N2 non\u2013small cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?","volume":"91","author":"Andre","year":"2001","journal-title":"Cancer"},{"issue":"5","key":"coi180128r17","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1200\/JCO.2001.19.5.1344","article-title":"Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma.","volume":"19","author":"Robnett","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi180128r18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0360-3016(98)00429-5","article-title":"Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.","volume":"43","author":"Cox","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi180128r19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0360-3016(97)00365-9","article-title":"Induction cisplatin\/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08\/ECOG 4588.","volume":"39","author":"Komaki","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"coi180128r20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0360-3016(91)90226-T","article-title":"ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d\u2019Etude et Traitement des Cancers Bronchiques), FNCLCC (F\u00e9deration Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.","volume":"20","author":"Arriagada","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"coi180128r21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.1981.03310300023013","article-title":"Cranial irradiation in cancer of the lung of all cell types.","volume":"245","author":"Cox","year":"1981","journal-title":"JAMA"},{"issue":"3","key":"coi180128r22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00253278","article-title":"Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer.","volume":"2","author":"Umsawasdi","year":"1984","journal-title":"J Neurooncol"},{"issue":"3","key":"coi180128r23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0360-3016(91)90681-S","article-title":"Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group.","volume":"21","author":"Russell","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi180128r24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2010.29.1609","article-title":"Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.","volume":"29","author":"Gore","year":"2011","journal-title":"J Clin Oncol"},{"key":"coi180128r25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"35","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"coi180128r27","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration.","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"1","key":"coi180128r28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2307\/2531632","article-title":"Study duration for clinical trials with survival response and early stopping rule.","volume":"46","author":"Kim","year":"1990","journal-title":"Biometrics"},{"key":"coi180128r29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion).","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"issue":"4","key":"coi180128r30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks.","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"issue":"2","key":"coi180128r31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2307\/2530862","article-title":"Testing for qualitative interactions between treatment effects and patient subsets.","volume":"41","author":"Gail","year":"1985","journal-title":"Biometrics"},{"issue":"3","key":"coi180128r32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1200\/JCO.2010.29.6053","article-title":"Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.","volume":"29","author":"Sun","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"coi180128r33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ijrobp.2013.02.033","article-title":"Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.","volume":"86","author":"Gondi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"coi180128r34","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/0360-3016(83)90319-X","article-title":"Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: correlation with survival.","volume":"9","author":"Komaki","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"coi180128r35","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy.","volume":"59","author":"Perez","year":"1987","journal-title":"Cancer"},{"issue":"2","key":"coi180128r36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.lungcan.2008.08.012","article-title":"Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.","volume":"64","author":"Wang","year":"2009","journal-title":"Lung Cancer"},{"issue":"2","key":"coi180128r37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0360-3016(98)00213-2","article-title":"Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).","volume":"42","author":"Komaki","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi180128r38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/annonc\/mdu567","article-title":"Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.","volume":"26","author":"Li","year":"2015","journal-title":"Ann Oncol"},{"issue":"23","key":"coi180128r39","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1200\/JCO.2017.77.5817","article-title":"Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: a randomized phase III NVALT-11\/DLCRG-02 Study.","volume":"36","author":"De Ruysscher","year":"2018","journal-title":"J Clin Oncol"},{"issue":"14","key":"coi180128r40","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"issue":"26","key":"coi180128r41","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1200\/JCO.2018.77.9363","article-title":"CNS efficacy of osimertinib in patients with T790M-positive advanced non-small-cell lung cancer: data from a randomized phase III trial (AURA3).","volume":"36","author":"Wu","year":"2018","journal-title":"J Clin Oncol"},{"issue":"13","key":"coi180128r42","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S1470-2045(15)00013-3","article-title":"Targeting brain metastases in ALK-rearranged non-small-cell lung cancer.","volume":"16","author":"Zhang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"2","key":"coi180128r43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1200\/JCO.2015.62.0138","article-title":"Extended survival and prognostic factors for patients with ALK-rearranged non-small-cell lung cancer and brain metastasis.","volume":"34","author":"Johung","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"coi180128r44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijrobp.2014.02.022","article-title":"Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma.","volume":"89","author":"Gerber","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"coi180128r45","first-page":"JCO2018783118","article-title":"CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer.","author":"Reungwetwattana","year":"2018","journal-title":"J Clin Oncol"},{"issue":"17","key":"coi180128r46","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1200\/JCO.2014.59.0539","article-title":"Clinical experience with crizotinib in patients with advanced ALK-rearranged non\u2013small-cell lung cancer and brain metastases.","volume":"33","author":"Costa","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi180128r47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/jnci\/87.3.183","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.","volume":"87","author":"Arriagada","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"coi180128r48","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S0959-8049(97)00135-4","article-title":"Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial.","volume":"33","author":"Gregor","year":"1997","journal-title":"Eur J Cancer"},{"issue":"1","key":"coi180128r49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijrobp.2010.05.013","article-title":"Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.","volume":"81","author":"Wolfson","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"coi180128r50","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/annonc\/mdq576","article-title":"Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).","volume":"22","author":"Le P\u00e9choux","year":"2011","journal-title":"Ann Oncol"},{"issue":"10","key":"coi180128r51","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"issue":"2","key":"coi180128r52","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijrobp.2007.05.038","article-title":"Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.","volume":"69","author":"Guti\u00e9rrez","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"coi180128r53","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"key":"coi180128r54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1748-717X-9-139","article-title":"Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy.","volume":"9","author":"Kazda","year":"2014","journal-title":"Radiat Oncol"},{"issue":"7","key":"coi180128r55","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S1470-2045(16)30065-1","article-title":"Prophylactic cranial irradiation for patients with lung cancer.","volume":"17","author":"P\u00e9choux","year":"2016","journal-title":"Lancet Oncol"},{"issue":"7","key":"coi180128r56","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"key":"coi180128r57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2407-1-5","article-title":"Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.","volume":"1","author":"Meert","year":"2001","journal-title":"BMC Cancer"},{"issue":"7","key":"coi180128r58","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer.","volume":"357","author":"Slotman","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"coi180128r59","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1093\/annonc\/mds123","article-title":"Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis.","volume":"23","author":"Schild","year":"2012","journal-title":"Ann Oncol"},{"issue":"20","key":"coi180128r60","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer.","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"issue":"24","key":"coi180128r61","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC.","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"coi180128r26","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch","year":"2011"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/5\/6\/847\/17667013\/jamaoncology_sun_2019_oi_180128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:14:43Z","timestamp":1721060083000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.7220"}},"subtitle":["A Long-term Update of the NRG Oncology\/RTOG 0214 Phase 3 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.7220","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}